Lite Strategy, Inc. — Director's Dealing 2023

Oct 13, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEI Pharma, Inc. (MEIP)
CIK: 0001262104
Period of Report: 2023-09-29

Reporting Person: GHALIE RICHARD G (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-09-29	Stock Option (Right to Buy)	$7.01	A	30000	Acquired	2033-09-29	Common Stock (30000)	Direct

Footnotes

F1: One quarter of such options shall vest as of July 1, 2024, with monthly vesting on the first day of each of the next 36 calendar months beginning on August 1, 2024.